Position in BIIB
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$167,148,114
+$22,588,197 QoQ
Shares Held
773,619
-1.9% QoQ
Ownership
0.524%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#32
of 1,036 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 88%
Shared 0%
None 12%
Common Shares in BIIB Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Bank of New York Mellon Corp holds $24,361,895,957 across 16 Drug Manufacturers - General names. BIIB ranks #10 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
4,783,459 | $5,737,424,695 | |
| 2 | JNJ |
Johnson & Johnson
|
21,683,347 | $5,506,919,623 | |
| 3 | ABBV |
AbbVie Inc.
|
12,853,368 | $3,234,421,512 | |
| 4 | MRK |
Merck & Co., Inc.
|
18,340,173 | $2,356,712,224 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
15,263,929 | $1,928,444,775 | |
| 6 | PFE |
Pfizer Inc
|
57,879,546 | $1,393,739,453 | |
| 7 | AMGN |
Amgen Inc
|
3,695,586 | $1,338,245,590 | |
| 8 | AZN |
Astrazeneca PLC
|
6,753,962 | $1,280,686,266 |
All Filings in BIIB
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $167,148,114 | 773,619 | Shares | Defined | 2026-08-06 | |
| 2026-03-31 | $144,559,917 | 788,523 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $142,746,536 | 811,106 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $123,928,909 | 884,701 | Shares | Defined | 2025-11-03 | |
| 2025-06-30 | $113,540,135 | 904,054 | Shares | Defined | 2025-08-05 | |
| 2025-03-31 | $130,519,489 | 953,811 | Shares | Defined | 2025-04-29 | |
| 2024-12-31 | $149,065,646 | 974,795 | Shares | Defined | 2025-02-04 | |
| 2024-09-30 | $194,447,681 | 1,003,135 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $289,222,099 | 1,247,615 | Shares | Defined | 2024-07-25 | |
| 2024-03-31 | $296,707,303 | 1,376,002 | Shares | Defined | 2024-04-25 | |
| 2023-12-31 | $359,612,141 | 1,389,698 | Shares | Defined | 2024-01-29 | |
| 2023-09-30 | $367,558,218 | 1,430,132 | Shares | Other | 2023-10-24 | |
| 2023-06-30 | $418,585,643 | 1,469,495 | Shares | Other | 2023-08-03 | |
| 2023-03-31 | $409,865,702 | 1,474,178 | Shares | Other | 2023-05-09 | |
| 2022-12-31 | $418,967,766 | 1,512,956 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $402,312,663 | 1,506,789 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $314,341,685 | 1,541,344 | Shares | Other | 2022-08-15 | |
| 2022-03-31 | $302,676,629 | 1,437,211 | Shares | Other | 2022-05-11 | |
| 2021-12-31 | $351,556,445 | 1,465,307 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $455,557,010 | 1,609,799 | Shares | Defined | 2021-11-18 | |
| 2021-06-30 | $611,454,640 | 1,765,832 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $609,043,160 | 2,177,098 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $525,492,080 | 2,146,092 | Shares | Defined | 2021-02-09 | |
| 2020-09-30 | $655,701,634 | 2,311,413 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $620,462,356 | 2,319,052 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $763,380,641 | 2,412,860 | Shares | Other | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||